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Background: Twist 1 is highly expressed in adipose tissue and has been associated with obesity and related
disorders. However, the molecular function of Twist 1 in adipose tissue is unclear. Twist 1 has been implicated in
cell lineage determination and differentiation. Therefore, we investigated both the role of Twist 1 in adipocyte
precursor mobilization and the relationship of Twist 1 with other molecular determinants of adipocyte
differentiation.
Methods: We examined Twist 1 mRNA and protein expression in subcutaneous adipose tissues from diet-induced
obese C57/BL6 mice and Wistar rats and in obese patients undergoing liposuction or adipose transplant surgeries.
Twist 1 expression was measured on days 0, 2, 4, 8, and 12 of 3T3-L1 differentiation in vitro. The role of Twist 1 in
adipogenesis was explored using retroviral interference of Twist 1 expression. Adipokine secretion was evaluated
using a RayBio® Biotin Label-based Adipokine Array.
Results: Twist 1 mRNA and protein levels were reduced in diet-induced obese mice and rats and in obese humans.
Twist 1 was upregulated during 3T3-L1 preadipocyte differentiation in vitro, beginning from the fourth day of
differentiation induction. Retroviral interference of Twist 1 expression did not significantly impair lipid formation;
however, retroviral interference induced PPARγ mRNA and protein expression on day 4 of differentiation induction.
Adipokine array analyses revealed increased secretion of CXCR4 (19.55-fold), VEGFR1 (92.13-fold), L-21 R (63.55-fold),
and IL-12 R beta 1 (59.66-fold) and decreased secretion of VEGFR3 (0.01-fold), TSLP R (0.071-fold), MIP-1 gamma
(0.069-fold), TNF RI/TNFRSF1A (0.09-fold), and MFG-E8 (0.06-fold).
Conclusions: Twist 1 is a regulator of adipocyte gene expression although it is not likely to regulate differentiation.
We identified PPARγ as a potential target of Twist 1 and found variation in the secretion of multiple adipokines,
which might indicate a prospective mechanism linking Twist 1 expression with obesity or associated diseases.
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Obesity has become an epidemic in the human population,
and China has the highest number of obese patients in the
world [1]. Because obesity involves an increase in the num-
ber of adipocytes, any of the factors involved in adipocyte
differentiation might be of great importance for the devel-
opment of obesity. To date, numerous factors and proteins
have been implicated in the generation of new fat cells, in-
cluding peroxisome proliferator-activated receptor gamma
(PPARγ) [2,3], CCAAT/enhancer binding protein (C/EBP,
which includes C/EBP α, C/EBP β, and C/EBP δ) [4,5],
adipocyte lipid binding protein (ALBP), and adipocyte de-
termination and differentiation factor 1 (ADD1) [6,7]. How-
ever, the relevance of those factors in the development of
obesity remains unclear.
Evidence suggests that PPARγ is a key player in adipo-
genesis and is expressed prior to other proteins during
early adipocyte differentiation. Among the three isoforms
(PPAR α, β/δ, and γ) in the PPAR family, PPARγ is most
specific to fat cells and exerts the strongest effect in adipo-
genesis. It is mainly expressed in adipose tissues and plays
an important role in lipid metabolism and the adipocyte
differentiation process. Previous studies have confirmed
that the expression of PPARγ during differentiation in-
duces the adipose phenotype, which is defined by lipid ac-
cumulation and the expression of other genes related to
this process [8]. Additionally, PPARγ is known to be
important in lipogenesis regulation, fatty acid metabolism,
insulin-mediated glucose transport, and lipid oxidation [9].
Thus, a greater understanding of PPARγ expression and
regulation is critical for understanding obesity and meta-
bolic syndrome (MS). Much attention has been devoted to
understanding pharmacologic activation of PPARγ [10].
However, the regulation of PPARγ expression, especially in
the early stages of adipose commitment, is largely un-
known. Studies on the transcription factors that control
PPARγ expression in adipose progenitors may provide
insight into adipocyte maturation in normal and obesity
states.
Twist 1, which belongs to the basic helix-loop-helix
family, is a well-conserved transcription factor that
plays a role in the formation of a variety of tissues, in-
cluding adipose tissue. Overexpression of Twist 1 has
been confirmed in human brown adipose tissue (BAT)
and white adipose tissue (WAT); however, the role of
Twist 1 in obesity is not well defined. Pettersson et al.
showed that Twist 1 might play a role in inflammation
of human WAT by regulating the expression and secre-
tion of inflammatory adipokines via direct transcrip-
tional effects in white adipocytes [11]. Pan et al. found
that Twist 1 interacted with PGC-1α, suppressed mito-
chondrial metabolism and uncoupling, and had an im-
portant role in the maintenance of energy homeostasis
in human BAT [12]. The relationship between Twist 1expression and the occurrence of obesity has gained at-
tention in recent years. Twist 1 expression was shown
to be downregulated in obese subjects and increased
after weight loss based on abdominal subcutaneous
WAT biopsy studies in 23 non-obese women and 107
obese women. The Twist 1 mRNA levels were corre-
lated with adiponectin levels and inversely correlated
with insulin resistance and adipocyte volume [13].
Further mechanisms of Twist 1 action in obesity devel-
opment, especially with respect to the specific mole-
cules involved in the underlying pathways, remain
unexplored.
The present study was designed to (1) explore the rela-
tionship between Twist 1 expression and obesity in both
diet-induced obese animal models and human subjects
and (2) determine the role of Twist 1 in adipose differenti-
ation and its potential relationship with the regulatory
molecules that are involved in this process. We found that
Twist 1 was negatively correlated with obesity develop-
ment and that retroviral interference of Twist 1 expression
did not impair the process of lipid formation in cultured
3T3-L1 preadipocytes; however, retroviral interference of
Twist 1 altered the expression of PPARγ and influenced
the secretion of multiple adipokines, mainly interleukins,
growth factors, chemokines, and their receptors, thus pro-
viding a prospective mechanism linking Twist 1 expres-
sion with obesity or obesity-associated diseases.
Results
Verification of diet-induced obesity models in C57/BL6
mice and Wistar rats
During breeding, four C57/BL6 mice and two Wistar rats
in the HFD-treated group died for unknown reasons,
while all animals in the control group remained alive.
Thus, there were 12 experimental animals in both of the
control groups, eight C57/BL6 mice in the HFD-treated
group, and ten Wistar rats in the HFD-treated group.
During breeding, the body weights of C57/BL6 mice and
Wistar rats increased gradually (Figure 1A/C). At the end
of the experiments, the body weight of obese C57/BL6
mice was 34.86 ± 2.98 g, which was significantly higher
than that of the control mice (26.15 ± 2.95 g; P < 0.05).
The body weight of obese Wistar rats was 438.61 ± 37.65
g, while that of the control rats was 342.66 ± 31.46 g (P <
0.05). Serum CHOL and GLU levels were both obviously
increased in obese mice and rats compared with the con-
trol (Figure 1B/D) (P < 0.05). However, no significant dif-
ference in TG levels was observed (P > 0.05).
Twist 1 gene transcription was significantly
downregulated in obese subjects
In both C57/BL6 mice (Figure 2A/B) and Wistar rats
(Figure 2C/D), Twist 1 gene transcription was significantly
decreased in obese animals compared with non-obese
Figure 1 Development and verification of diet-induced obesity
models in C57/BL6 mice and Wistar rats. (A) Change in the body
weight of C57/BL6 mice during the development of the obesity
model. (B) Serum CHOL, TG, and GLU levels of C57/BL6 mice were
assayed. CHOL and GLU were obviously increased in obese mice
compared to the control group (The data are presented as the mean ±
SE. *P< 0.05, control vs. high-fat diet group). (C) Change in the body
weight of Wistar rats during the development of the obesity model.
(D) Serum CHOL, TG, and GLU levels of Wistar rats were assayed.
CHOL and GLU were obviously increased in obese mice compared to
the control (*P< 0.05, control vs. high-fat diet group).
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ware verified this decrease (P < 0.05). We further confirmed
this decrease in Twist 1 in clinically obese patients with a
BMI ≥ 30 compared with non-obese patients (Figure 2E/F)
(P < 0.05).Twist 1 expression was significantly downregulated in
obese subjects
In C57/BL6 mice (Figure 3A/B), Wistar rats (Figure 3C/D),
and clinical patients (Figure 3E/F), Twist 1 protein expres-
sion was significantly downregulated in obese subjects com-
pared with relatively non-obese subjects based on western
blot analysis (P < 0.05).
Twist 1 was upregulated during 3T3-L1 adipocyte
differentiation
Morphological observations revealed that the lipid droplets
were distributed as a ring in the cytoplasm. Oil red O stain-
ing showed clear red dye in the adipocytes; however, this
dye was not observed in the preadipocytes (Figure 4A).
Quantitative analysis of the intracellular oil red O by spec-
trophotometry demonstrated the accumulation of lipids
(Figure 4B). The levels of PPARγ and ALBP were signifi-
cantly increased beginning at day 2 post-differentiation
induction, and the levels peaked on day 12 (Figure 4C)
(P < 0.05).
The dynamic changes in Twist 1 expression were mea-
sured by collecting cells at different time points during
differentiation, including days 0, 2, 4, 8, and 12. The re-
sults demonstrated the upregulation of Twist 1 mRNA
(Figure 4D/F) and protein (Figure 4E/G) beginning on
the 4th day of differentiation induction (P < 0.05).
Retroviral interference of Twist 1 expression had no
significant effect on lipid formation in 3T3-L1
preadipocytes
Western blot analysis demonstrated that the expression of
Twist 1 was 70-80% reduced in Twist 1 shRNA-treated
cells compared with its expression in vector-treated con-
trol cells (Figure 5A/B). When induced to differentiate,
the Twist 1 shRNA-treated cells showed no obvious differ-
ences in intracellular lipid accumulation (P > 0.05)
(Figure 5C/D). The expression levels of the PPARγ and
ALBP proteins were increased in the Twist 1 shRNA-
treated cells compared with the vector-treated control
cells under hormone-induced differentiation. (Figure 5E).
Retroviral interference of Twist 1 expression enhanced
the expression of PPARγ on day 4 of hormone-induced
differentiation
The mRNA level of PPARγ was assayed by real time
PCR, and the results are expressed as the fold change
compared to the control. The data were analyzed using
the 2-ΔΔ Ct method. The results confirmed the upregu-
lation of PPARγ on day 4 of differentiation induction
(P < 0.05); however, there were no obvious differences at
the other time points (P > 0.05) (Figure 6A). A western
blot assay confirmed the increased expression of PPARγ
on day 4 of differentiation induction (P < 0.05), although
there was no obvious difference at the other time points
Figure 2 Twist 1 transcription was downregulated in the adipose tissue of obese subjects. (A/B) An obesity model was established in C57/BL6J
mice that were fed a high-fat diet for 14 weeks. Twist 1 transcription was downregulated significantly in subcutaneous adipose tissue compared with
its level in the control groups (*P < 0.05 vs. control). (C/D) An obesity model was established in Wistar rats that were fed a high-fat diet, and a reduced
Twist 1 mRNA level was observed in subcutaneous adipose tissue (*P < 0.05 vs. control). (E/F) The level of Twist 1 transcription in the subcutaneous
adipose tissues of individuals with a BMI≥ 30 was lower than in non-obese individuals (*P < 0.05 vs. 20 < BMI < 25 group).
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with the results of the real-time PCR.
Adipokine array analyses showed that the secretion of
multiple adipokines was altered by Twist 1 siRNA
retroviral interference in 3T3-L1 preadipocytes
As shown in Figure 7, the levels of twenty adipokines were
increased by more than two-fold in the media of the Twist
1 shRNA-treated cells, including vascular endothelial
growth factor receptor 1 (VEGFR1, 92.13-fold), interleukin
21 receptor (IL-21 R, 63.55-fold), interleukin 12 receptorFigure 3 Twist 1 protein expression was decreased in the adipose tissu
adipose tissue from obese C57/BL6J mice was significantly downregulated co
(C/D) Twist 1 expression was reduced in subcutaneous adipose tissues from o
1 in subcutaneous adipose tissues from individuals with a BMI≥ 30 was show
group, P < 0.05).beta 1 (IL-12 R beta 1, 59.66-fold), Cys-X-Cys receptor 4
(CXCR4, 19.55-fold), fibroblast growth factor receptor 3
(FGF R3, 29.79-fold), and growth hormone receptor (GHR,
5.94-fold) (Figure 7B).
The levels of a total of fifty-seven adipokines were de-
creased. There was a greater than 5-fold change ob-
served in the adipokines shown in Figure 7C, including
VEGFR3 (0.01-fold), thymic stromal lymphopoietin re-
ceptor (TSLP R, 0.071-fold), macrophage inflammatory
protein 1 gamma (MIP-1 gamma, 0.069-fold), TNF RI/
TNFRSF1A (0.09-fold), milk fat globule EGF factor 8e of obese subjects. (A/B) The expression of Twist 1 in subcutaneous
mpared with its expression in the control groups (*P < 0.05 vs. control).
bese Wistar rats (*P < 0.05 vs. control). (E/F) The expression level of Twist
n to be lower than the level in non-obese individuals (* vs. 20 < BMI < 25
Figure 4 3T3-L1 preadipocytes were induced to differentiate in vitro, and the dynamic expression of Twist 1 was detected. (A)
Morphological observations and oil red O staining of 3T3-L1 preadipocytes and adipocytes. (B) Quantitative analysis of intracellular oil red O staining
using spectrophotometry. (C) PPARγ and ALBP protein expression levels at different stages of 3T3-L1 preadipocyte differentiation. (D/F) The dynamic
transcription of Twist 1 was detected at different stages of 3T3-L1 preadipocyte differentiation (*P < 0.05 vs. control, day 0 cells). (E/G) The dynamic
expression of Twist 1 was detected at different stages of 3T3-L1 preadipocyte differentiation (*P < 0.05 vs. control, day 0 cells).
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Discussion
In this study, we provide evidence indicating that a mo-
lecular mechanism links Twist 1 expression to obesity or
associated diseases. We found that retroviral interference
of Twist 1 expression induced the expression of PPARγ
during differentiation induction and increased the secre-
tion of multiple adipokines into the medium; however,
interference of Twist 1 expression did not significantly
impair the process of lipid formation, indicating a poten-
tial role for Twist 1 in obesity and associated diseases.
Increasing evidence indicates that Twist 1 plays an im-
portant part in the development of obesity [14]. Previous
studies have demonstrated that Twist 1 expression was
decreased in subcutaneous WAT from 107 obese women
compared with 23 non-obese (non-ob.) subjects, and the
expression of Twist 1 was restored after weight loss [13].
The results presented here also revealed the downregu-
lation of Twist 1 in obese individuals compared with
non-obese individuals; these results are consistent with
the results of several earlier studies. Regarding thespecies-organ expression of Twist 1, our analysis was
conducted based on different species obesity models, in-
cluding Wistar rats, C57/BL6 mice, and humans with
different BMI values; these studies confirmed the de-
crease in Twist 1 levels in obesity.
Some recent studies have examined the molecular
mechanism underlying the role of Twist 1 in obesity; how-
ever, the subject remains largely unexplored. In this study,
we demonstrated that Twist 1 mRNA and protein levels
were upregulated during 3T3-L1 differentiation; these re-
sults were similar to those described in previous reports
on human preadipocyte differentiation in vitro [11]. No
significant difference in differentiation was found between
preadipocytes with Twist 1 interference and vector control
cells; however, the role of Twist 1 in cell differentiation
has been demonstrated in the dental pulp of extracted hu-
man third molars (DPSCs), and the forced expression of
Twist 1 in DPSCs has been shown to alter the potential of
these cells to differentiate into odontoblast-like cells [15].
Coincidentally, retroviral overexpression of Twist 1 in a
brown fat preadipocyte cell line and in white fat preadipo-
cyte 3T3-L1 cells had no significant effect on adipogenic
differentiation in a previous study using oil red O staining
Figure 5 The role of Twist 1 in adipogenesis was explored using
retroviral interference of Twist 1 expression. (A/B) Retroviral
interference of Twist 1 expression was conducted using LV3. Western
blot analysis showed that Twist 1 expression was reduced to 70-80% of
the control. (C/D) Oil red O staining was used to analyze the
differentiation of 3T3-L1/NC and 3T3-L1/Twist 1- cells. The results
showed that interference of Twist 1 did not influence the
differentiation, and there were no significant differences among the
groups. (E) The expression levels of the PPARγ and ALBP proteins were
increased in the Twist 1 shRNA-treated cells compared with the
vector-treated control cells under hormone-induced differentiation.
The infection time for both Twist 1/shRNA and LV3/NC was 48 h.
Figure 6 Retroviral interference of Twist 1 expression enhanced
the expression of PPARγ on day 4 of hormone-induced
differentiation. (A) Real-time PCR analysis revealed that PPARγ mRNA
was upregulated on day 4 of hormone-induced differentiation after
retroviral interference of Twist 1 expression compared with its
expression level in 3T3-L1/NC cells (*P < 0.05 vs. day 0). (B/C) PPARγ
protein expression on day 4 of hormone-induced differentiation was
significantly enhanced when Twist 1 expression was downregulated;
there were no obvious differences at the other time points (*P < 0.05
vs. 3T3-L1/NC cells at day 4). The infection time for both Twist 1/shRNA
and LV3/NC was 48 h.
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red O staining; however, we also determined the expres-
sion levels of differentiation marker genes, including
PPARγ and ALBP, due to the multiple confounding factors
related to oil red O staining.
We determined the expression of PPARγ in preadipo-
cyte clones, with or without Twist 1 interference, duringdifferentiation induction. No prominent differences were
observed in the different differentiation periods; how-
ever, comparisons at the same time points revealed an
interesting result. Compared with the retroviral vector-
transformed control cells, retroviral interference of Twist
1 expression in 3T3-L1 preadipocytes upregulated the
mRNA and protein levels of PPARγ on day 4 of differen-
tiation induction. The reason for this difference was un-
clear; however, this observation may indicate multiple
possibilities due to the complex and diverse role of
PPARγ and might provide a better understanding of the
molecular basis underlying the important properties of
Twist 1 as a target for obesity and associated diseases.
For example, Twist 1 might influence the physiological
and pathological processes related to PPARγ during the
Figure 7 The secretion of various adipokines by cultured 3T3-L1
adipocytes with or without Twist 1 interference was evaluated
using a Mouse Antibody Array. (A) Data from the array analyses
with filter 1, which was treated with medium from the adipocytes
infected with LV3/NC for 48 h (Left), and filter 2, which was treated
with medium from the adipocytes infected with Twist 1/shRNA for 48
h (Right). (B) The values obtained from the scans were adjusted based
on the intensity of the control spots on the filter corners, and the
elevated levels of specific adipokines are shown. (C) Adipokines that
were decreased by more than five fold in the medium of Twist
1-knockdown cells are listed.
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PPARγ was important in brown fat metabolism, along
with some other transcription factors including PPARα,
ERRα, NRF1, and PGC-1α. Twist-1 is believed to sup-
press PGC-1α activity during this process by direct
interaction through the C-terminal region of PGC-1α
(aa 353–797). This protein-protein interaction of PGC-
1α with Twist 1 may not be independent of PPARγ [16].
A regulatory cascade involving PPARγ and TWIST1 was
found in low-grade chronic inflammation in humans,
which is a major characteristic of obesity and results
from deregulated white adipose tissue function. Treat-
ment of diabetic obese patients with pioglitazone, an
antidiabetic and anti-inflammatory PPARγ agonist, re-
stored the expression of TWIST1 in adipose tissue [17].
Our results suggested a possible mechanism underlying
the role of Twist 1 in obesity that is based on the mul-
tiple biological functions of PPARγ. PPARγ maytherefore serve as an important molecular bridge be-
tween Twist 1 and obesity.
The levels of adipokines in the conditioned medium of
3T3-L1/Twist 1- cells were determined. Traditionally,
adipokines are detected using enzyme-linked immuno-
sorbent assays (ELISAs); however, the sensitivity and
variability of this assay limit its application. In recent
years, adipokine antibody arrays have become popular
because this method can simultaneously detect multiple
adipokines [18-20]. In the current study, a RayBio® Bio-
tin Label-based Mouse Antibody Array was used to de-
tect 308 adipokines related directly or indirectly to Twist
1 expression with high specificity. The results showed
changes in the secretion of multiple adipokines, and the
targeted adipokines were mainly divided into three cat-
egories. The first group consisted of interleukins (includ-
ing IL-3, IL-6, IL-7, IL-9, IL-10, IL-17, IL-21, and IL-27)
and their receptors. Studies exploring the roles of inter-
leukins in obesity or associated diseases have been re-
ported [21-24]. A lack of the interleukin-1 receptor I
(IL-1 RI) was demonstrated to ameliorate high-fat diet
(HFD)-induced insulin resistance (IR) by attenuating
adipose tissue inflammation [25]. IL-1β is thought to
support ectopic fat accumulation in hepatocytes and
adipose-tissue macrophages by promoting adipose in-
flammation and limiting fat tissue expandability, contrib-
uting to impaired fat-liver crosstalk in nutritional obesity
[26]. In obesity-associated asthma, the development of
airway hyperreactivity (AHR) is thought to be dependent
on IL-17A and the NLRP3 inflammasome [27]. Here, we
extended the knowledge regarding the function of the IL
family in Twist 1-related obesity and associated diseases.
The second group consisted of growth factors and their
receptors, especially FGF, GHR, HGF, VEGF, TNF, and
their receptors. The roles of several of these molecules in
obesity have been described [28-32]; however, the import-
ance of these molecules to Twist 1-related obesity remains
unknown. The third group consisted of chemokine family
members and related proteins, including CXCR4, Cys-Cys
receptor 6 (CCR6), and monocyte chemotactic protein-1
(MCP-1). These results are consistent with the results of
recent studies [13,33-37]. There is clear evidence for the
participation of the chemokine system in the development
of obesity and obesity-induced pathologies [38]. However,
much remains unknown about their roles in Twist 1-
related obesity.
This study had some limitations. For example, it is not
clear whether Twist 1 directly regulates PPARγ expres-
sion or how PPARγ acts as a molecular bridge among
the Twist 1-related processes in obesity. The pathway
from Twist 1 expression to alterations in the secretion
of multiple adipokines is also not clear. Repeated ana-
lyses of the adipokine array are important; however,
these were not completed in the current study because
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tial avenues for our future studies.
We showed that retroviral interference of Twist 1 ex-
pression induced the expression of PPARγ during differ-
entiation induction and altered the secretion of multiple
adipokines, including interleukin, growth factors, che-
mokines, and their receptors; however, the interference
did not significantly impair the process of lipid forma-
tion. These results indicate the existence of a potential
mechanism linking Twist 1 expression and obesity or
obesity-associated diseases (Figure 8).
Materials and methods
Materials
The animals, including C57/BL6 mice and Wistar rats,
were purchased from the Experimental Animal Center of
Shandong University. The 3T3-L1 mouse embryo fibro-
blasts were obtained from the American Type Culture
Collection (ATCC, Washington, USA) (No. CL-173).
Dulbecco’s modified Eagle’s medium (DMEM) was pro-
duced by the ATCC (No. 30–2002). Bovine serum and
fetal bovine serum (FBS) were purchased from GIBCO
(Invitrogen, California, USA). The RayBio® Biotin Label-
based Mouse Antibody Array I was obtained from
RayBiotech, Inc. (Norcross, GA). The primary antibodies
anti-Twist 1, anti-PPARγ, anti-ALBP, and anti-β-actin wereFigure 8 A model for possible role of Twist 1 in obesity or
obesity-related diseases. The expression of Twist 1 influences the
transcription and protein expression of PPARγ during differentiation
induction and alters the secretion of multiple adipokines into the
medium, either directly or indirectly. Then, altered PPARγ or adipokines
play roles in obesity-related physiological process, but not in
adipogenesis, which further regulates obesity or obesity-related
diseases.purchased from Abcam. All primers used in this study were
synthesized at the Genomics Institute of HuaDa in Beijing.
All other reagents, including insulin, dexamethasone (Dex),
and isobutylmethylxanthine (IBMX), were purchased from
Sigma (St. Louis, MO, USA).
Obesity induction in C57/BL6 mouse and Wistar rat
models and subsequent analyses
Twenty-four adult male C57/BL6 mice aged 6 weeks and
twenty-four adult male Wistar rats aged 3 months were
purchased from the Experimental Animal Center of
Shandong University. The C57/BL6 mice were housed 6
to a cage, and the Wistar rats were housed 3 to a cage.
The animals were maintained in a controlled environment
at 25°C with 55% relative humidity under a 12/12-h light/
dark cycle; they were provided free access to tap water
and food. After one week of adaptation, the mice and rats
were randomly divided into two groups with 12 animals
per group: the “control group” (normal chow, 4% fat) and
the “high-fat group” (high-fat diet, 20% fat). The basal and
high-fat diet were both purchased from Beijing Ke Ao Xie
Li Feed Co., Ltd, and detailed information regarding these
diets has been published previously [39]. The body weight
of each animal was determined once per week for 14
weeks until the animals were sacrificed by deep anesthesia
with 0.3% pentobarbital sodium (1 ml/kg, intraperitoneal
injection). The animal experiments were performed in ac-
cordance with the ‘Principles of Laboratory Animal Care’
established by the National Institutes of Health and were
approved by the Animal Care and Use Committee of
Shandong University.
Blood was collected in EDTA-coated tubes after fasting
the mice for 12 h, and the serum was separated by centrifu-
gation (500 × g, 4°C, 10 min). Serum cholesterol (CHOL),
triglycerides (TG), and glucose (GLU) levels were measured
using the Beckman DXC 800 analyzer (Beckman Coulter,
Inc., California, USA). All biochemical measurements were
carried out at the Department of Laboratory Medicine of
Shandong Provincial Qianfoshan Hospital. Subcutaneous
adipose tissue samples were collected and quickly frozen by
immediate immersion into liquid nitrogen. They were then
stored at −80°C prior to mRNA and protein extraction to
determine Twist 1 mRNA and protein expression levels.
Human fat sample collection
A total of 90 patients who underwent liposuction or fat
transplant surgeries at Shandong Provincial Qianfoshan
Hospital affiliated with Shandong University from 2011 to
2013 were recruited for this study. All patients were eu-
thyroid, had no history of diabetes, and had no family his-
tory of obesity. Subcutaneous adipose tissue samples were
collected. Written informed consent was obtained from
all of the patients before surgery, and the study was ap-
proved by the Ethics Committee of Shandong University.
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tient body mass index (BMI) (calculated as body weight
(BW) in kilograms over squared height in meters): the
slim group (15 cases, BMI ≤ 20); the normal group (26
cases, 20 < BMI < 25); the overweight group (21 cases,
25 ≤ BMI < 30); and the obesity group (28 cases, BMI ≥
30). The basic clinical characteristics of these patients are
shown in Table 1. The clinically relevant BMI divisions for
Asians, in which obesity is a BMI greater than 27, were
not applied here. Instead, we considered a BMI greater
than 30 to be indicative of obesity. The collected adipose
tissue samples were also analyzed to determine Twist 1
mRNA and protein expression.
Adipose tissue pretreatment
Lipids in adipose tissues interfere with PCR and western
blot analyses. Therefore, removal of the majority of the
triglycerides from the adipose tissues before further ana-
lyses was essential. We used pre-cooled acetone to dis-
solve the fat as previously described [39]. Importantly,
we ensured that a sufficient amount of acetone was used
for full lipid extraction, performed appropriate intermit-
tent shaking during the incubation at 4°C, and mini-
mized protein degradation by using protease inhibitors.
After centrifugation, the lipid droplets appeared in the
upper layer, while the other components of the cells
remained in the bottom of the tube. The upper layers
were removed and discarded as carefully as possible.
The procedure was repeated if visible lipids remained.
Preadipocyte differentiation induction and oil red O
staining
The 3T3-L1 preadipocytes were maintained in DMEM
supplemented with 10% bovine serum, 100 U/ml penicil-
lin, and 100 mg streptomycin at 37°C in a humidified at-
mosphere composed of 95% air and 5% CO2. Preadipocyte
differentiation induction and oil red O staining were con-
ducted as previously described [39].
Knockdown of Twist 1 in 3T3-L1 preadipocytes
The lentivirus vector pGLV-H1-GFP/Puro (pLV3) was
used to generate the shRNA that targeted Twist 1 ac-
cording to the manufacturer’s instructions. The oligo
sequence of the siRNA targeting Twist 1 was 5’-Table 1 Information regarding human samples collected from
BMI Number Sex
Male Fe
BMI≤ 20 15 6
20 < BMI≤ 25 26 8
25 < BMI≤ 30 21 9
BMI > 30 28 11
Total 90 34ACTCCAAGATGGCAAGCTG-3’. Packaged viruses en-
coding an shRNA targeting Twist 1 based on the obtained
plasmids (pLV3/Twist 1-shRNA) were applied to cultured
293T cells according to the manufacturer’s instructions.
The blank pLV3 vector was used to generate virus without
siRNA as a control. After infection for 48–72 h, the 293T
cells were centrifuged, and the supernatants (containing
virus) were used to infect 3T3-L1 cells once the cells had
reached 70-80% confluence. Twenty-four hours post-
infection, stable transfectants were selected based on
puromycin resistance and green fluorescent protein (GFP)
expression under fluorescence microscopy. The cells sta-
bly expressing the pLV3 vector were used as a control.
The preadipocytes with Twist 1 expression interference
and those expressing the pLV3 vector were induced to dif-
ferentiate as described above, and adipocytes or condi-
tioned media were collected for transcription, protein
expression, and adipokine array analyses.
RT-PCR and real-time PCR
Total RNA was extracted using TRIzol (Invitrogen) ac-
cording to the manufacturer’s instructions. Comple-
mentary DNA (cDNA) was synthesized using the
ExScript RT reagent kit (Takara Bio, Otsu, Shiga, Japan)
following the manufacturer’s instructions. The detailed
RT-PCR protocol used to analyze Twist 1 gene expres-
sion has been previously described, and β-actin was
used as a control [39]. Real-time PCR was performed to
quantify PPARγ mRNA using a CFX96TM Real-Time
System (Bio-Rad) by monitoring the increase in fluores-
cence of SYBR Green, which is a double-stranded dye
that specifically binds DNA. The real-time PCR reac-
tions were carried out in a final volume of 20 μl, includ-
ing 1 μl of cDNA sample, 1 μl of each primer, and 10 μl
of 2x Ultra SYBR Mixture (product no. cw0956). The
cycling conditions were 95°C for 10 min followed by 40
cycles of 95°C for 15 s, 60°C for 1 min, and 72°C for 30
s. The relative mRNA expression level of the target se-
quence was determined as the fold change compared
with the control (β-actin mRNA) using the 2-ΔΔ Ct
method or Image J software analysis. All measurements
were conducted in triplicate. The PCR primers were de-
signed using Primer 5.0 Software, and the sequences are
as follows:the clinic
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β-actin-R: 5’-GCCGGACTCATCGTACTCC-3’Western blot analysis
Total protein was extracted using radio immunoprecipi-
tation assay (RIPA) lysis buffer containing protease and
phosphatase inhibitors according to the manufacturer’s
instructions. The protein concentration was determined
based on a Bradford protein assay. The proteins (80 μg
from each sample) were resolved on SDS-PAGE gels,
transferred to a Hybond-P PVDF membrane, and incu-
bated with primary antibodies (anti-Twist 1 (1:1000),
anti-PPARγ (1:1000), anti-ALBP (1:500), or anti-β-actin
(1:2500)) overnight at 4°C. Twist 1, PPARγ, ALBP, and
β-actin bands were visualized at apparent molecular
weights of 21 kDa, 58 kDa, 15 kDa, and 43 kDa,
respectively, by incubation with peroxidase-conjugated
anti-rabbit or anti-mouse secondary antibodies (1:5000
dilution) for 1 h at room temperature. The relative OD
ratio was calculated with Image J software by compari-
son with β-actin; data from three experiments were
analyzed.Adipokine array
The ability of 3T3-L1 adipocytes to secrete various adipo-
kines into conditioned media after Twist 1 interference
was evaluated and compared with that of control cells
using a RayBio® Biotin Label-based Mouse Antibody Array
I obtained from RayBiotech, Inc. (Norcross, GA). The
assay was performed according to the manufacturer’s
protocol and could be used to simultaneously detect 308
adipokines with high specificity. Briefly, 2 ml of 1× block-
ing buffer was added to each membrane, and the mem-
branes were incubated at room temperature for 30 min.
The membranes were then incubated with 1 ml of the
sample at room temperature for 2 h. The samples were
decanted from each container and washed 3 times with
wash buffer at room temperature with shaking for 5 min.
Blocking buffer (1×, 100 μl) was added to the biotin-
conjugated anti-adipokine tube. Diluted biotin-conjugated
antibodies (1 ml) were added to each membrane. The
membranes were then incubated at room temperature for
2 h and washed with washing buffer. Next, 2 ml of 1000-
fold diluted HRP-conjugated streptavidin was added to
each membrane. The membranes were incubated at room
temperature for 2 h, washed with washing buffer, and ex-
posed to X-ray film. The signal was detected using a film
developer or directly on the membrane using a chemilu-
minescence imaging system.Statistical analysis
The data are presented as the mean ± standard error of
the mean (SEM). Comparisons between the means of
two groups were analyzed using a t test. One-way ana-
lysis of variance (ANOVA) was performed when there
were more than 2 groups using the SPSS 16.0 software
package. A q test was used for further pairwise compari-
sons. P values of less than 0.05 were considered statisti-
cally significant.
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